Stock Information
Denali Therapeutics Inc (DNLI)
Ticker Symbol: DNLI
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,028.57 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.969
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -50.13%
Latest News
-
Arista Networks To Rally Around 43%? Here Are 10 Top Analyst Forecasts For Tuesday
Tue, Apr 7, 2026 9:10 AM
-
Baird Maintains Outperform on Denali Therapeutics, Raises Price Target to $34
Tue, Apr 7, 2026 6:48 AM
-
Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why
Mon, Apr 6, 2026 1:26 PM
-
Reported Friday, Denali Therapeutics Regains Full Rights To DNL593 After Takeda Terminates Collaboration, Phase 1/2 FTD-GRN Trial Results Expected By End Of 2026
Mon, Apr 6, 2026 3:03 AM
Key Financials
Financial data not available
